Cargando…
Effect of comorbid pulmonary disease on the severity of COVID‐19: A systematic review and meta‐analysis
Coronavirus disease 2019 (COVID‐19) caused by infection with severe acute respiratory syndrome coronavirus 2 was first detected in Wuhan, China, in late 2019 and continues to spread worldwide. Persistent questions remain about the relationship between the severity of COVID‐19 and comorbid diseases,...
Autores principales: | Gülsen, Askin, König, Inke R., Jappe, Uta, Drömann, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207055/ https://www.ncbi.nlm.nih.gov/pubmed/33955623 http://dx.doi.org/10.1111/resp.14049 |
Ejemplares similares
-
The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis
por: Gülsen, Askin, et al.
Publicado: (2020) -
Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events*
por: Gülsen, Askin, et al.
Publicado: (2020) -
Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events
por: Gülsen, Askin, et al.
Publicado: (2020) -
Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis
por: Gülsen, Askin, et al.
Publicado: (2021) -
Prevalence and mortality of lung comorbidities among patients with COVID-19: A systematic review and meta-analysis
por: Alkhathami, Mohammed G., et al.
Publicado: (2021)